[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
aponia_analytics @AponiaAnalytics on x 4965 followers
Created: 2025-07-17 18:20:09 UTC
🦉 New dual agonists like tirzepatide intensify appetite suppression, but side effects like muscle loss and facial fat wasting complicate long-term use without new mitigation strategies. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #obesity #GLP1
XXX engagements
Related Topics pfe hims manat $hims $vani $zldpf $rhhby $gsk